Delivery Order SPE2DB22D2009-SPE2DB25FL8SP
Award Date
4/9/25
Potential Completion Date
4/10/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Olmesartan Medoxomil 40 mg tablets. The contract has a ceiling value of $2,275.38 and a completion date of February 7, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,730.19, is a delivery order for the supply of Olmesartan Medoxomil 40 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,382.90, is for the supply of Olmesartan Medoxomil 40 mg tablets to support military healthcare programs. The contract is a firm fixed-price, delivery order type with an ultimate completion date of January 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,580.62, is for the delivery of Olmesartan Medoxomil 40 MG Tablets in 90-count packages. This is a firm fixed-price Delivery Order with a completion date of February 14, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,877.34, is for the supply of Olmesartan Medoxomil 40 mg tablets in 30-count packages. The contract has a period of performance through January 3, 2025 and utilizes a Firm Fixed Price pricing type. This award is associated with Amerisourcebergen's larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,826.72 firm fixed-price contract is for the delivery of Olmesartan Medoxomil 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of November 16, 2023 and was awarded on November 15, 2023. This contract is part of a larger $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,210.58, is for the delivery of Olmesartan Medoxomil 40 mg tablets in 90-count packages. The contract type is firm fixed price, and the ultimate completion date is February 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,453.89 fixed-price delivery order is for the supply of 4,562,817,379 units of the drug Olmesartan Medoxomil 40 mg tablets, with a completion date of November 15, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $8,494.92 for the supply of Olmesartan Medoxomil 40 mg tablets. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 29, 2024. The contract type is Firm Fixed Price, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,162.48, is for the delivery of Olmesartan Medoxomil 40 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of December 17, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of...